TNF promotes DECTIN2 family C-type lectin receptor expression in human macrophages
Open Access
- 14 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 113 (6) , 615-625
Abstract
TNF blockade constitutes an effective therapy for inflammatory bowel disease (IBD), yet increases the risk for infection including active tuberculosis. The DECTIN2 family C-type lectin receptors (CLR) MINCLE, MCL and DECTIN2 sense mycobacterial ligands and activate myeloid cells. In mice, upregulation of DECTIN2 family CLR after stimulation with Mycobacterium bovis Bacille Calmette-Guerin (BCG) requires TNF. Here, we investigated whether TNF controls inducible CLR expression in human myeloid cells. Monocyte-derived macrophages (MDM) were stimulated with BCG and the TLR4 ligand LPS, and expression of CLR was analyzed. BCG and LPS strongly upregulated mRNA expression of DECTIN2 family CLR, but not of DECTIN1. BCG and LPS also induced robust production of TNF. Recombinant TNF was sufficient to upregulate expression of DECTIN2 family CLR. Blocking TNF with the TNFR2-Fc fusion protein Etanercept abrogated, as expected, the effect of recombinant TNF, and impaired induction of DECTIN2 family CLR by BCG and LPS. Flow cytometry confirmed upregulation of MCL at the protein level by recombinant TNF and showed inhibition of BCG-induced MCL by Etanercept. To investigate the impact of TNF on CLR expression in vivo, we analyzed PBMC of patients with IBD and observed down-regulation of MINCLE and MCL expression after therapeutic TNF blockade. Together, TNF is sufficient to upregulate DECTIN2 family CLR in human myeloid cells and contributes to this process after encounter with BCG or LPS. Impaired CLR expression in patients receiving TNF blockade may dampen the sensing of microbes and defense against infection.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 40 references indexed in Scilit:
- The Dectin-2 family of C-type lectin-like receptors: an updateInternational Immunology, 2013
- In Vitro Generation of Monocyte-Derived Macrophages under Serum-Free Conditions Improves Their Tumor Promoting FunctionsPLOS ONE, 2012
- Effect of Infliximab on Gene Expression Profiling in Behçet's DiseaseInvestigative Ophthalmology & Visual Science, 2011
- The adaptor molecule CARD9 is essential for tuberculosis controlJournal of Experimental Medicine, 2010
- Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-DibehenateThe Journal of Immunology, 2010
- Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleJournal of Experimental Medicine, 2009
- Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulationJournal of Leukocyte Biology, 2005
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?Annals of the Rheumatic Diseases, 2003
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995